FAQs

A pharma competitive intelligence platform that monitors drug pipelines, clinical trials, FDA and EMA activity, patent cliffs, news and competitors across all therapy areas. You define what matters; we screen everything for it continuously and link every claim to its source. Set your focus once and we keep your landscape current as the market moves, with no digging through spreadsheets and no waiting on a consultant's report.

RxClarity uses AI to ingest and map pharma data, and to apply documented pharma-specific rules that flag opportunity and risk signals. The rules, not free-form model judgement, decide what gets surfaced, and every output links back to the record behind it, so you can check it.

General AI tools work from a mix of web scraping and connectors, and may be trained on data months out of date. RxClarity works from a curated, connected database of drug, trial and company relationships, reviewed by experts, and shows the evidence behind every claim. Grounding answers in a maintained database is significantly more accurate than a standalone general model.

Two ways. First, you define the criteria and we execute them across everything, rather than handing you a dashboard to search or a report written at you. Second, every result shows the specific signal that triggered it and links to its source, so you can trust it enough to act. We're a structured, queryable decision layer, not a document generator.

Our register includes multi-regional studies run in China and trials from Chinese sponsors seeking international visibility; both register on ClinicalTrials.gov, which we ingest daily. It doesn't yet include domestic trials registered only with ChiCTR; we plan to add ChiCTR data later this year.

We are offering 50% discount for early customers. This includes dashboard, our agent for chat and your custom agents. See Pricing.

Soon. We're opening free landscape briefs in batches as coverage completes. Join the list and we'll produce yours in the first batch for your therapy area.